In a crucial five-year study conducted between 2019 and 2023, a team of researchers led by Hui Zeng investigated the distribution and resistance patterns of different pathogens in the Intensive Care Unit (ICU) of a newly established hospital in Guizhou Province, China. This significant endeavor was aimed at promoting the rational use of antibiotics to reduce multidrug resistance – a rapidly increasing menace in modern healthcare.
In a systematic yet retrospective manner, the research team analyzed the distribution of pathogens and changes in drug resistance within the ICU. Over this period, 2444 culture samples were collected, primarily originating from sputum (34.66%) and blood (23.36%), with a steadily increasing diversity in specimen types each year. The isolated organisms consisted of 345 Gram-negative bacteria (60.31%), 135 Gram-positive cocci (23.60%), and 92 fungi (16.08%), with the most frequent pathogens being Acinetobacter baumannii (30.77%), Candida albicans (11.71%), and Klebsiella pneumoniae (9.97%).
The study’s analysis of drug sensitivity tests revealed a fluctuation in resistance rates of Acinetobacter baumannii over the five years. Furthermore, Staphylococcus aureus displayed strong in vitro activity against vancomycin, tigecycline, and linezolid, with no resistant strains identified. Alarmingly, high detection rates were found for carbapenem-resistant Acinetobacter baumannii, carbapenem-resistant Pseudomonas aeruginosa, methicillin-resistant Staphylococcus aureus, and strains producing extended-spectrum beta-lactamases.
The research findings underscore the pressing need for effective infection control measures in ICU environments. Such measures include enhanced monitoring of drug-resistant bacteria, improved management of antibacterial drugs, and the pursuit of new therapeutic options. Subsequently, these efforts will assist in preventing nosocomial infections and encourage the appropriate use of antibiotics. This study paves the way for future research, exploring strategies to manage the distribution and resistance patterns of ICU pathogens better. It is pivotal in providing reference data for infection management and advocating for the rational use of antibiotics in newly established healthcare settings.